FDA To Look At Efficacy Of LASIK Surgery

Law360, New York (March 18, 2008, 12:00 AM EDT) -- The U.S. Food and Drug Administration reportedly intends to take a harder look at LASIK surgery in the wake of concerns about the popular operation that aims to correct poor vision.

On Monday, Dr. Daniel Schultz, the director of the FDA's center for devices and radiological health, revealed the agency's plan to hold a public meeting to discuss the issues surrounding laser-assisted in situ keratomileusis, or LASIK, Reuters reported.

"Obviously, it's a technology that has caught on and is used very, very widely,” Schultz said. “And...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.